AU2002229976A1 - Imidazopyridines - Google Patents

Imidazopyridines

Info

Publication number
AU2002229976A1
AU2002229976A1 AU2002229976A AU2002229976A AU2002229976A1 AU 2002229976 A1 AU2002229976 A1 AU 2002229976A1 AU 2002229976 A AU2002229976 A AU 2002229976A AU 2002229976 A AU2002229976 A AU 2002229976A AU 2002229976 A1 AU2002229976 A1 AU 2002229976A1
Authority
AU
Australia
Prior art keywords
imidazopyridines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229976A
Inventor
Alexander Graham Dossetter
Peter Kenny
Darren Mckerrecher
Michael Wardleworth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002229976A1 publication Critical patent/AU2002229976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002229976A 2001-02-20 2002-02-15 Imidazopyridines Abandoned AU2002229976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100567A SE0100567D0 (en) 2001-02-20 2001-02-20 Compounds
SE0100567-7 2001-02-20
PCT/GB2002/000634 WO2002066477A2 (en) 2001-02-20 2002-02-15 Imidazopyridines

Publications (1)

Publication Number Publication Date
AU2002229976A1 true AU2002229976A1 (en) 2002-09-04

Family

ID=20283057

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229976A Abandoned AU2002229976A1 (en) 2001-02-20 2002-02-15 Imidazopyridines

Country Status (3)

Country Link
AU (1) AU2002229976A1 (en)
SE (1) SE0100567D0 (en)
WO (1) WO2002066477A2 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10246890A1 (en) * 2002-10-08 2004-04-22 Grünenthal GmbH New C-(imidazo-(1,2-a)-pyridin-3-yl)-methylamines, are nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, septic shock, neurodegenerative diseases, inflammatory pain or cancer
DE10247271A1 (en) * 2002-10-10 2004-08-26 Grünenthal GmbH Use of new and known 7-(methyl or trifluoromethyl)-imidazo-(1,2-a)-pyridines as nitrogen monoxide synthase inhibitors useful e.g. for treating migraine, neurodegenerative diseases, inflammatory pain, diabetes or cancer
GB0320806D0 (en) 2003-09-05 2003-10-08 Astrazeneca Ab Therapeutic treatment
WO2005044818A2 (en) 2003-10-28 2005-05-19 Sepracor, Inc. Imidazo[1,2-a]pyridine anxiolytics
GB0403781D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical compounds
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008506702A (en) 2004-07-14 2008-03-06 ピーティーシー セラピューティクス，インコーポレーテッド Method for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7645881B2 (en) 2004-07-22 2010-01-12 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US20090281120A1 (en) 2005-12-12 2009-11-12 Ono Pharmaceutical Co., Ltd Bicyclic heterocyclic compound
RU2008143179A (en) 2006-03-31 2010-05-10 Новартис АГ (CH) ORGANIC COMPOUNDS
WO2008027812A2 (en) 2006-08-28 2008-03-06 Forest Laboratories Holdings Limited Imidazopyridine and imidazopyrimidine derivatives
EP2070927A4 (en) * 2006-09-13 2010-10-13 Kyowa Hakko Kirin Co Ltd Fused heterocyclic derivative
CA2672172C (en) 2006-12-22 2016-05-03 Astex Therapeutics Limited Bicyclic heterocyclic compounds as fgfr inhibitors
CN101679409B (en) 2006-12-22 2014-11-26 Astex治疗学有限公司 Bicyclic heterocyclic derivative compound, pharmaceutical compositions and uses thereof
EP1964840A1 (en) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines and their use as pharmaceuticals
WO2008124323A1 (en) 2007-04-03 2008-10-16 Array Biopharma Inc. Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
CA2703649A1 (en) * 2007-10-24 2009-04-30 Shigeyuki Tanifuji Novel compound having affinity for amyloid
EP2300470A2 (en) * 2008-05-19 2011-03-30 Sepracor Inc. Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
TW201242965A (en) 2011-02-01 2012-11-01 Kyowa Hakko Kirin Co Ltd Ring-fused heterocyclic derivative
US8975276B2 (en) 2011-06-29 2015-03-10 Bristol-Myers Squibb Company Inhibitors of PDE10
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
KR20150036763A (en) 2012-07-31 2015-04-07 교와 핫꼬 기린 가부시키가이샤 Condensed ring heterocyclic compound
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
MA52119A (en) 2015-10-19 2018-08-29 Ncyte Corp HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS
SG11201804152RA (en) 2015-11-19 2018-06-28 Incyte Corp Heterocyclic compounds as immunomodulators
ES2844374T3 (en) 2015-12-22 2021-07-22 Incyte Corp Heterocyclic compounds as immunomodulators
US9926316B2 (en) 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
EP3452476B1 (en) 2016-05-06 2021-12-15 Incyte Corporation Heterocyclic compounds as immunomodulators
TW201808902A (en) 2016-05-26 2018-03-16 美商英塞特公司 Heterocyclic compounds as immunomodulators
ES2927984T3 (en) 2016-06-20 2022-11-14 Incyte Corp Heterocyclic compounds as immunomodulators
ES2930092T3 (en) 2016-07-14 2022-12-07 Incyte Corp Heterocyclic compounds as immunomodulators
ES2941716T3 (en) 2016-08-29 2023-05-25 Incyte Corp Heterocyclic compounds as immunomodulators
US20180179179A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
ES2874756T3 (en) 2016-12-22 2021-11-05 Incyte Corp Triazolo [1,5-A] pyridine derivatives as immunomodulators
EP3558985B1 (en) 2016-12-22 2022-09-07 Incyte Corporation Benzooxazole derivatives as immunomodulators
MX2019007651A (en) 2016-12-22 2020-02-07 Incyte Corp Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers.
MX2020010321A (en) 2018-03-30 2021-01-08 Incyte Corp Heterocyclic compounds as immunomodulators.
DK3790877T3 (en) 2018-05-11 2023-04-24 Incyte Corp TETRAHYDRO-IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS PD-L1 IMMUNE MODULATORS
EP4010342A1 (en) 2019-08-09 2022-06-15 Incyte Corporation Salts of a pd-1/pd-l1 inhibitor
CA3155852A1 (en) 2019-09-30 2021-04-08 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
MX2022005651A (en) 2019-11-11 2022-07-27 Incyte Corp Salts and crystalline forms of a pd-1/pd-l1 inhibitor.
WO2022099018A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Process of preparing a pd-1/pd-l1 inhibitor
JP2023548859A (en) 2020-11-06 2023-11-21 インサイト・コーポレイション Process for making PD-1/PD-L1 inhibitors and their salts and crystalline forms
WO2022099075A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Crystalline form of a pd-1/pd-l1 inhibitor
CN113666926A (en) * 2021-09-08 2021-11-19 桂林理工大学 Convenient Michal addition reaction of 2-phenylimidazole [1,2-a ] pyridine and chalcone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544212A1 (en) * 1995-11-28 1997-06-05 Asta Medica Ag New LH-RH antagonists with improved effects
CN1077107C (en) * 1996-07-19 2002-01-02 武田药品工业株式会社 Heterocyclic compounds, their production and use
AU9621598A (en) * 1997-10-20 1999-05-10 Novo Nordisk A/S Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive
WO1999041252A1 (en) * 1998-02-11 1999-08-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
WO1999041251A1 (en) * 1998-02-11 1999-08-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
PT1255738E (en) * 2000-01-25 2012-06-19 Neurocrine Biosciences Inc Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
KR100830859B1 (en) * 2000-04-27 2008-05-21 아스텔라스세이야쿠 가부시키가이샤 Imidazopyridine derivatives and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
WO2002066477A2 (en) 2002-08-29
SE0100567D0 (en) 2001-02-20
WO2002066477A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
AU2002229976A1 (en) Imidazopyridines
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2002313565A1 (en) Putter-heads
AU2002308154A1 (en) Triazolopyrimidines
AU2002319532A1 (en) Feeding-bottles
AU2002330025A1 (en) Atlastin
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2002233664A1 (en) Naphthyridine derivative
AU2001100406A4 (en) DriverSMS
AU2002313073A1 (en) Phytocystatin
AU2002257925A1 (en) Numberplates
AU2001100338A4 (en) Sunglove
AU2001100522A4 (en) e-Trans
AU2001100532A4 (en) FonePark
AU2001100214A4 (en) Dolly-trolley
AU2002100746A4 (en) Adrail
AU2002221442A1 (en) Aminoacid-iodine complex
AU2002304671A1 (en) Triazolopyrimidines
AU2002317000A1 (en) Morpholine-bridged pyrazolopyridine derivatives
AU2002253687A1 (en) Floss-pick
AU2002312695A1 (en) Mini-scooter
AU2002235675A1 (en) Regakine-1
AU2002249693A1 (en) Starseparator
AU2002325847A1 (en) Bromonitrothienyldioxans

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase